Status:
UNKNOWN
Long Term Oxygen Therapy in Patients With Interstitial Lung Disease
Lead Sponsor:
Assiut University
Conditions:
Long Term Oxygen Therapy
Interstitial Lung Disease
Eligibility:
All Genders
18-70 years
Brief Summary
Study the effect of using long term oxygen therapy in patients with interstitial lung disease and chronic hypoxia
Detailed Description
long term oxygen can be used in patients with interstitial lung disease with hypoxia and the aim of this study is to k ow whether this will improve life style , exercise tolerance in those patients
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- patients with ILD and hypoxia with SO2\<88 at room air and PO2 \< or equal 7.3k.pa or \< or equal 8 k.pa in presence of lower limb edema , pulmonary hypertension or polycythemia
- age group 18 : 70
- Exclusion Criteria :
- Causes of chronic respiratory failure other than ILD.
Exclusion
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04089826
Start Date
September 1 2019
End Date
October 1 2020
Last Update
September 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.